Concentration dependency of an acyl glucuronide metabolite in eltrombopag‐induced hepatotoxicity: Role of UGT1A1 genotype
British Journal of Clinical Pharmacology · 2026-08 · 92 (8) · 2853-2862
DOI: 10.1002/bcp.70585 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Clinical Pharmacology, online erschienen am 28.04.2026. Verfasst von Shun Oda und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Ibaraki, Japan. Hauptthemen laut MEDLINE: Glucuronosyltransferase, Hydrazines, Benzoates, Pyrazoles. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Aim
Eltrombopag, a thrombopoietin receptor agonist for aplastic anaemia, can cause hepatotoxicity. It is metabolized by uridine diphosphate‐glucuronosyltransferase (UGT) 1A1 to form an acyl glucuronide metabolite; however, the relationships among serum concentrations of the acyl glucuronide metabolite, UGT1A1 genotypes and hepatotoxicity remain unclear.
Method
We examined the serum concentrations of eltrombopag and its acyl glucuronide metabolite, UGT1A1 genotypes and occurrence of hepatotoxicity (abnormal liver function tests or drug‐induced liver injury [DILI]) in 104 samples from 42 patients with aplastic anaemia receiving eltrombopag.
Results
The concentrations of eltrombopag and its acyl glucuronide metabolite were significantly higher in samples with abnormal liver function than in those with normal liver function (23.0 ± 18.5 vs . 10.6 ± 9.3 μg/mL and 6.9 ± 4.5 vs . 2.1 ± 1.2 μg/mL, respectively). Receiver operating characteristic (ROC) analysis demonstrated that the concentration of the acyl glucuronide metabolite provided superior predictive accuracy for hepatotoxicity, with a threshold of 4.0 μg/mL, compared with eltrombopag (area under the ROC curve, 0.83 vs . 0.68). All patients with DILI had higher concentrations of the acyl glucuronide metabolite than the cutoff value. The incidence of hepatotoxicity differed across UGT1A1 genotype: 43% in extensive metabolizers (EMs), 11% in intermediate metabolizers (IMs) and none in poor metabolizers (PMs). The formation of the acyl glucuronide metabolite was 1.5‐fold greater in EMs than in IMs/PMs.
Conclusion
These findings suggest that eltrombopag‐induced hepatotoxicity is dependent on the concentration of eltrombopag acyl glucuronide and influenced by UGT1A1 genotype, highlighting the potential utility of serum acyl glucuronide monitoring and UGT1A1 genotyping for preventing and managing the hepatotoxicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Ibaraki, Japan.
- Department of Pharmacy, University of Tsukuba Hospital, Tsukuba, Ibaraki, Japan.
- Department of Hematology, Institute of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.
- Division of Advanced Hemato-Oncology, Transborder Medical Research Center, University of Tsukuba, Tsukuba, Ibaraki, Japan.
ORCID-Profile: Kosuke Doki
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Oda, S., Doki, K., Obara, N., Suzuki, Y., Sakata-Yanagimoto, M., & Homma, M. (2026). Concentration dependency of an acyl glucuronide metabolite in eltrombopag‐induced hepatotoxicity: Role of UGT1A1 genotype. British Journal of Clinical Pharmacology, 92(8), 2853-2862. https://doi.org/10.1002/bcp.70585
Vancouver
Oda S, Doki K, Obara N, Suzuki Y, Sakata-Yanagimoto M, Homma M. Concentration dependency of an acyl glucuronide metabolite in eltrombopag‐induced hepatotoxicity: Role of UGT1A1 genotype. British Journal of Clinical Pharmacology. 2026;92(8):2853-2862. doi:10.1002/bcp.70585
BibTeX
@article{Oda2026,
author = {Oda, Shun and Doki, Kosuke and Obara, Naoshi and Suzuki, Yoshiharu and Sakata-Yanagimoto, Mamiko and Homma, Masato},
title = {Concentration dependency of an acyl glucuronide metabolite in eltrombopag‐induced hepatotoxicity: Role of UGT1A1 genotype},
journal = {British Journal of Clinical Pharmacology},
year = {2026},
volume = {92},
number = {8},
pages = {2853--2862},
doi = {10.1002/bcp.70585}
}
EUVIMED